Strategies and Approaches of Targeting STAT3 for Cancer Treatment-Reference-Cited by-同舟云学术

Strategies and Approaches of Targeting STAT3 for Cancer Treatment

Published:2016-01-15 Issue:2 Volume:11 Page:308-318
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Furtek Steffanie L.¹,Backos Donald S.¹,Matheson Christopher J.¹,Reigan Philip¹

Affiliation:

1. Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, 12850 East Montview Boulevard, Aurora, Colorado 80045, United States

Funder

Morgan Adams Foundation

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acschembio.5b00945

Reference103 articles.

1. STATs and Gene Regulation

2. A novel small-molecule disrupts Stat3 SH2 domain–phosphotyrosine interactions and Stat3-dependent tumor processes

3. STAT inhibitors for cancer therapy

4. Regulation of STAT signaling by acetylation

5. Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application

Cited by 315 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments;Bioorganic Chemistry;2024-10

2. Analysis of action of 1,4-naphthoquinone scaffold-derived compounds against acute myeloid leukemia based on network pharmacology, molecular docking and molecular dynamics simulation;Scientific Reports;2024-09-09

3. C188-9 reduces patient-specific primary breast cancer cells proliferation at the low, clinic-relevant concentration;Journal of Translational Medicine;2024-08-22

4. Lycorine combined with cisplatin synergistically inhibited osteosarcoma cells growth and metastasis by suppressing Wnt/β-Catenin and STAT3 signaling pathways;Journal of Functional Foods;2024-08

5. Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma;Translational Oncology;2024-08